Orphan drugs: a challenge for the pharmaceutical industry in Europe
Gespeichert in:
Hauptverfasser: | , |
---|---|
Format: | Buch |
Sprache: | English |
Veröffentlicht: |
Nürnberg
Univ. Erlangen-Nürnberg, Lehrstuhl für Gesundheitsmanagement
2005
Burgdorf Herz |
Schriftenreihe: | Schriften zur Gesundheitsökonomie
6 |
Schlagworte: | |
Online-Zugang: | Inhaltsverzeichnis |
Beschreibung: | Literatuverz. S. 133 - 141. - Hergestellt on demand |
Beschreibung: | XIV, 141 S. graph. Darst. 21 cm |
ISBN: | 3936863059 |
Internformat
MARC
LEADER | 00000nam a2200000 cb4500 | ||
---|---|---|---|
001 | BV021726107 | ||
003 | DE-604 | ||
005 | 20070921 | ||
007 | t | ||
008 | 060911s2005 gw d||| |||| 00||| eng d | ||
015 | |a 05,N31,0177 |2 dnb | ||
015 | |a 06,B09,0338 |2 dnb | ||
016 | 7 | |a 975617958 |2 DE-101 | |
020 | |a 3936863059 |c (Herz) kart. : EUR 19.90 |9 3-936863-05-9 | ||
024 | 3 | |a 9783936863055 | |
035 | |a (OCoLC)71813957 | ||
035 | |a (DE-599)BVBBV021726107 | ||
040 | |a DE-604 |b ger |e rakddb | ||
041 | 0 | |a eng | |
044 | |a gw |c XA-DE-BY | ||
049 | |a DE-29 |a DE-12 |a DE-19 | ||
082 | 1 | |a 615.19094 |2 22//ger | |
082 | 0 | |a 615.19094 |2 22/ger | |
084 | |a QX 700 |0 (DE-625)142186: |2 rvk | ||
084 | |a XC 5300 |0 (DE-625)152521:12905 |2 rvk | ||
084 | |a 610 |2 sdnb | ||
100 | 1 | |a Hagn, Daniel |e Verfasser |4 aut | |
245 | 1 | 0 | |a Orphan drugs |b a challenge for the pharmaceutical industry in Europe |c Daniel Hagn ; Oliver Schöffski. [Universität Erlangen-Nürnberg, Lehrstuhl für Gesundheitsmanagement. Health-Economics-Research-Zentrum] |
264 | 1 | |a Nürnberg |b Univ. Erlangen-Nürnberg, Lehrstuhl für Gesundheitsmanagement |c 2005 | |
264 | 1 | |a Burgdorf |b Herz | |
300 | |a XIV, 141 S. |b graph. Darst. |c 21 cm | ||
336 | |b txt |2 rdacontent | ||
337 | |b n |2 rdamedia | ||
338 | |b nc |2 rdacarrier | ||
490 | 1 | |a Schriften zur Gesundheitsökonomie |v 6 | |
500 | |a Literatuverz. S. 133 - 141. - Hergestellt on demand | ||
650 | 0 | 7 | |a Arzneimittelentwicklung |0 (DE-588)4143176-5 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Arzneimittelversorgung |0 (DE-588)4140783-0 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Seltene Krankheit |0 (DE-588)4180919-1 |2 gnd |9 rswk-swf |
650 | 0 | 7 | |a Gesundheitspolitik |0 (DE-588)4113743-7 |2 gnd |9 rswk-swf |
651 | 7 | |a Europa |0 (DE-588)4015701-5 |2 gnd |9 rswk-swf | |
689 | 0 | 0 | |a Europa |0 (DE-588)4015701-5 |D g |
689 | 0 | 1 | |a Seltene Krankheit |0 (DE-588)4180919-1 |D s |
689 | 0 | 2 | |a Arzneimittelentwicklung |0 (DE-588)4143176-5 |D s |
689 | 0 | 3 | |a Gesundheitspolitik |0 (DE-588)4113743-7 |D s |
689 | 0 | |5 DE-604 | |
689 | 1 | 0 | |a Europa |0 (DE-588)4015701-5 |D g |
689 | 1 | 1 | |a Seltene Krankheit |0 (DE-588)4180919-1 |D s |
689 | 1 | 2 | |a Arzneimittelversorgung |0 (DE-588)4140783-0 |D s |
689 | 1 | 3 | |a Gesundheitspolitik |0 (DE-588)4113743-7 |D s |
689 | 1 | |C b |5 DE-604 | |
700 | 1 | |a Schöffski, Oliver |d 1961- |e Verfasser |0 (DE-588)114870810 |4 aut | |
830 | 0 | |a Schriften zur Gesundheitsökonomie |v 6 |w (DE-604)BV017303654 |9 6 | |
856 | 4 | 2 | |m DNB Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=014939703&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
999 | |a oai:aleph.bib-bvb.de:BVB01-014939703 |
Datensatz im Suchindex
_version_ | 1804135570506514432 |
---|---|
adam_text |
|
adam_txt | |
any_adam_object | 1 |
any_adam_object_boolean | 1 |
author | Hagn, Daniel Schöffski, Oliver 1961- |
author_GND | (DE-588)114870810 |
author_facet | Hagn, Daniel Schöffski, Oliver 1961- |
author_role | aut aut |
author_sort | Hagn, Daniel |
author_variant | d h dh o s os |
building | Verbundindex |
bvnumber | BV021726107 |
classification_rvk | QX 700 XC 5300 |
ctrlnum | (OCoLC)71813957 (DE-599)BVBBV021726107 |
dewey-full | 615.19094 |
dewey-hundreds | 600 - Technology (Applied sciences) |
dewey-ones | 615 - Pharmacology and therapeutics |
dewey-raw | 615.19094 |
dewey-search | 615.19094 |
dewey-sort | 3615.19094 |
dewey-tens | 610 - Medicine and health |
discipline | Wirtschaftswissenschaften Medizin |
discipline_str_mv | Wirtschaftswissenschaften Medizin |
format | Book |
fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02688nam a2200625 cb4500</leader><controlfield tag="001">BV021726107</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20070921 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">060911s2005 gw d||| |||| 00||| eng d</controlfield><datafield tag="015" ind1=" " ind2=" "><subfield code="a">05,N31,0177</subfield><subfield code="2">dnb</subfield></datafield><datafield tag="015" ind1=" " ind2=" "><subfield code="a">06,B09,0338</subfield><subfield code="2">dnb</subfield></datafield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">975617958</subfield><subfield code="2">DE-101</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">3936863059</subfield><subfield code="c">(Herz) kart. : EUR 19.90</subfield><subfield code="9">3-936863-05-9</subfield></datafield><datafield tag="024" ind1="3" ind2=" "><subfield code="a">9783936863055</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)71813957</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV021726107</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="044" ind1=" " ind2=" "><subfield code="a">gw</subfield><subfield code="c">XA-DE-BY</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-29</subfield><subfield code="a">DE-12</subfield><subfield code="a">DE-19</subfield></datafield><datafield tag="082" ind1="1" ind2=" "><subfield code="a">615.19094</subfield><subfield code="2">22//ger</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615.19094</subfield><subfield code="2">22/ger</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">QX 700</subfield><subfield code="0">(DE-625)142186:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">XC 5300</subfield><subfield code="0">(DE-625)152521:12905</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">610</subfield><subfield code="2">sdnb</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Hagn, Daniel</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Orphan drugs</subfield><subfield code="b">a challenge for the pharmaceutical industry in Europe</subfield><subfield code="c">Daniel Hagn ; Oliver Schöffski. [Universität Erlangen-Nürnberg, Lehrstuhl für Gesundheitsmanagement. Health-Economics-Research-Zentrum]</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Nürnberg</subfield><subfield code="b">Univ. Erlangen-Nürnberg, Lehrstuhl für Gesundheitsmanagement</subfield><subfield code="c">2005</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Burgdorf</subfield><subfield code="b">Herz</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XIV, 141 S.</subfield><subfield code="b">graph. Darst.</subfield><subfield code="c">21 cm</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="1" ind2=" "><subfield code="a">Schriften zur Gesundheitsökonomie</subfield><subfield code="v">6</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Literatuverz. S. 133 - 141. - Hergestellt on demand</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelentwicklung</subfield><subfield code="0">(DE-588)4143176-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneimittelversorgung</subfield><subfield code="0">(DE-588)4140783-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Seltene Krankheit</subfield><subfield code="0">(DE-588)4180919-1</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Gesundheitspolitik</subfield><subfield code="0">(DE-588)4113743-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="651" ind1=" " ind2="7"><subfield code="a">Europa</subfield><subfield code="0">(DE-588)4015701-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Europa</subfield><subfield code="0">(DE-588)4015701-5</subfield><subfield code="D">g</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Seltene Krankheit</subfield><subfield code="0">(DE-588)4180919-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="2"><subfield code="a">Arzneimittelentwicklung</subfield><subfield code="0">(DE-588)4143176-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="3"><subfield code="a">Gesundheitspolitik</subfield><subfield code="0">(DE-588)4113743-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">Europa</subfield><subfield code="0">(DE-588)4015701-5</subfield><subfield code="D">g</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Seltene Krankheit</subfield><subfield code="0">(DE-588)4180919-1</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="2"><subfield code="a">Arzneimittelversorgung</subfield><subfield code="0">(DE-588)4140783-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="3"><subfield code="a">Gesundheitspolitik</subfield><subfield code="0">(DE-588)4113743-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="C">b</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Schöffski, Oliver</subfield><subfield code="d">1961-</subfield><subfield code="e">Verfasser</subfield><subfield code="0">(DE-588)114870810</subfield><subfield code="4">aut</subfield></datafield><datafield tag="830" ind1=" " ind2="0"><subfield code="a">Schriften zur Gesundheitsökonomie</subfield><subfield code="v">6</subfield><subfield code="w">(DE-604)BV017303654</subfield><subfield code="9">6</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">DNB Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=014939703&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-014939703</subfield></datafield></record></collection> |
geographic | Europa (DE-588)4015701-5 gnd |
geographic_facet | Europa |
id | DE-604.BV021726107 |
illustrated | Illustrated |
index_date | 2024-07-02T15:24:50Z |
indexdate | 2024-07-09T20:42:36Z |
institution | BVB |
isbn | 3936863059 |
language | English |
oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-014939703 |
oclc_num | 71813957 |
open_access_boolean | |
owner | DE-29 DE-12 DE-19 DE-BY-UBM |
owner_facet | DE-29 DE-12 DE-19 DE-BY-UBM |
physical | XIV, 141 S. graph. Darst. 21 cm |
publishDate | 2005 |
publishDateSearch | 2005 |
publishDateSort | 2005 |
publisher | Univ. Erlangen-Nürnberg, Lehrstuhl für Gesundheitsmanagement Herz |
record_format | marc |
series | Schriften zur Gesundheitsökonomie |
series2 | Schriften zur Gesundheitsökonomie |
spelling | Hagn, Daniel Verfasser aut Orphan drugs a challenge for the pharmaceutical industry in Europe Daniel Hagn ; Oliver Schöffski. [Universität Erlangen-Nürnberg, Lehrstuhl für Gesundheitsmanagement. Health-Economics-Research-Zentrum] Nürnberg Univ. Erlangen-Nürnberg, Lehrstuhl für Gesundheitsmanagement 2005 Burgdorf Herz XIV, 141 S. graph. Darst. 21 cm txt rdacontent n rdamedia nc rdacarrier Schriften zur Gesundheitsökonomie 6 Literatuverz. S. 133 - 141. - Hergestellt on demand Arzneimittelentwicklung (DE-588)4143176-5 gnd rswk-swf Arzneimittelversorgung (DE-588)4140783-0 gnd rswk-swf Seltene Krankheit (DE-588)4180919-1 gnd rswk-swf Gesundheitspolitik (DE-588)4113743-7 gnd rswk-swf Europa (DE-588)4015701-5 gnd rswk-swf Europa (DE-588)4015701-5 g Seltene Krankheit (DE-588)4180919-1 s Arzneimittelentwicklung (DE-588)4143176-5 s Gesundheitspolitik (DE-588)4113743-7 s DE-604 Arzneimittelversorgung (DE-588)4140783-0 s b DE-604 Schöffski, Oliver 1961- Verfasser (DE-588)114870810 aut Schriften zur Gesundheitsökonomie 6 (DE-604)BV017303654 6 DNB Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=014939703&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
spellingShingle | Hagn, Daniel Schöffski, Oliver 1961- Orphan drugs a challenge for the pharmaceutical industry in Europe Schriften zur Gesundheitsökonomie Arzneimittelentwicklung (DE-588)4143176-5 gnd Arzneimittelversorgung (DE-588)4140783-0 gnd Seltene Krankheit (DE-588)4180919-1 gnd Gesundheitspolitik (DE-588)4113743-7 gnd |
subject_GND | (DE-588)4143176-5 (DE-588)4140783-0 (DE-588)4180919-1 (DE-588)4113743-7 (DE-588)4015701-5 |
title | Orphan drugs a challenge for the pharmaceutical industry in Europe |
title_auth | Orphan drugs a challenge for the pharmaceutical industry in Europe |
title_exact_search | Orphan drugs a challenge for the pharmaceutical industry in Europe |
title_exact_search_txtP | Orphan drugs a challenge for the pharmaceutical industry in Europe |
title_full | Orphan drugs a challenge for the pharmaceutical industry in Europe Daniel Hagn ; Oliver Schöffski. [Universität Erlangen-Nürnberg, Lehrstuhl für Gesundheitsmanagement. Health-Economics-Research-Zentrum] |
title_fullStr | Orphan drugs a challenge for the pharmaceutical industry in Europe Daniel Hagn ; Oliver Schöffski. [Universität Erlangen-Nürnberg, Lehrstuhl für Gesundheitsmanagement. Health-Economics-Research-Zentrum] |
title_full_unstemmed | Orphan drugs a challenge for the pharmaceutical industry in Europe Daniel Hagn ; Oliver Schöffski. [Universität Erlangen-Nürnberg, Lehrstuhl für Gesundheitsmanagement. Health-Economics-Research-Zentrum] |
title_short | Orphan drugs |
title_sort | orphan drugs a challenge for the pharmaceutical industry in europe |
title_sub | a challenge for the pharmaceutical industry in Europe |
topic | Arzneimittelentwicklung (DE-588)4143176-5 gnd Arzneimittelversorgung (DE-588)4140783-0 gnd Seltene Krankheit (DE-588)4180919-1 gnd Gesundheitspolitik (DE-588)4113743-7 gnd |
topic_facet | Arzneimittelentwicklung Arzneimittelversorgung Seltene Krankheit Gesundheitspolitik Europa |
url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=014939703&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
volume_link | (DE-604)BV017303654 |
work_keys_str_mv | AT hagndaniel orphandrugsachallengeforthepharmaceuticalindustryineurope AT schoffskioliver orphandrugsachallengeforthepharmaceuticalindustryineurope |